• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Neuren`s NNZ-2591 shows benefit in rare neurodevelopmental disorder

    PR NEWSWIRE

    Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome

    BIOSPACE

    The Neuren Pharmaceuticals (ASX:NEU) share price has soared 102%

    FOOL

    Neuren submits IND application for NNZ-2591 in Phelan-McDermid syndrome

    THEMARKETHERALD

    ACADIA announce Rare Pediatric Disease Designation for Trofinetide

    BIOSPECTRUM ASIA

    ACADIA & Neuren Announce Rare Pediatric Disease Designation for Trofinetide

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.